![]() |
市场调查报告书
商品编码
1380263
2023-2030年全球光疗设备市场Global Phototherapy Equipment Market 2023-2030 |
全球光疗设备市场按产品、应用和最终用户细分。根据产品,市场分为传统光疗设备、LED光疗设备和光纤光疗设备。根据应用,市场细分为皮肤病治疗和新生儿黄疸管理。此外,根据最终用户,市场分为医院、诊所和家庭护理。其中,LED光疗设备细分市场预计将占据相当大的市场份额。基于 LED 的光疗用于治疗细纹、牛皮癣和痤疮等皮肤病。患有此类皮肤病的人数的增加预计将增加对 LED 光疗设备的需求。痤疮是人们最常见的皮肤病。据估计,11 至 30 岁的人中 80% 至少患有轻度痤疮,使其成为全球第八大流行疾病。
其中,皮肤病治疗细分领域预计将在全球光疗设备市场中占据相当大的份额。光疗是治疗多种皮肤病的高效疗法。光疗使用特定波长的光来减少发炎、减缓皮肤细胞增殖并促进癒合。光疗是一种非侵入性治疗选择,不需要外科手术或服用药物。这对于喜欢非药物治疗或不能服用某些药物的人来说是一个不错的选择。光疗还可以透过抑制过度活跃的免疫反应来减少与牛皮癣相关的发红、肿胀和搔痒。
美国、中国和印度等国家皮肤病的增加导致光疗设备的使用量增加。据国家银屑病基金会称,银屑病影响着美国超过 800 万人和全球 1.25 亿人。遗传至关重要,因为如果父母之一患有牛皮癣,那么孩子患牛皮癣的几率约为 28%。如果父母双方都患有牛皮癣,孩子患牛皮癣的几率约为 65%。在白斑症和斑秃等自体免疫皮肤病中,免疫系统会错误地攻击健康细胞,导致色素脱失或掉髮。光疗可以帮助改变免疫反应,降低身体对组织的攻击。
全球光疗设备市场根据地理位置进一步细分,包括北美(美国和加拿大)、欧洲(英国、义大利、西班牙、德国、法国和欧洲其他地区)、亚太地区(印度、中国、日本) 、韩国和亚洲其他地区)以及世界其他地区(中东和非洲以及拉丁美洲)。其中,由于北美地区的增长,预计北美将在全球市场中占据显着份额。新生儿黄疸和皮肤病的发生以及人们对使用新技术的认识不断提高。
在所有地区中,由于医院和专科诊所建设不断增加以提供有效的医疗保健解决方案,预计亚太地区在预测期内将以相当大的CAGR增长。除此之外,大众医疗保健支出的增加也促进了市场的成长。 2019年,中国医疗保健进出口额双双成长,达到2011年以来的最高水准。欧洲、亚洲、北美是中国医疗保健对外贸易的三大大陆合作伙伴。影响中国该产业的主要因素和驱动因素,特别是中国政府在发布关键发展计画和法规方面日益发挥的支持作用,以及中国人口的快速老化。中国医药产业一直在稳步扩张,预计到2023年底将达到1,618亿美元,约占全球市场的30%。但由于中国头部製药企业和跨国跨国製药公司(包括美国製药公司)占了大部分市场销售,美国中小企业製药公司的开拓机会受到限制。
服务光疗设备市场的主要公司包括: Daavlin Company、Aeroflow, Inc.、Philips Lighting Holding BV、Signify Holding、Atom Medical Corporation、Herbert Waldmann GmbH & Co. KG、Hill-Rom Holdings, Inc. 等。市场参与者透过各种策略(包括併购、合作、合作、融资和新产品发布),为市场成长做出了巨大贡献,以保持市场竞争力。例如,2022 年 4 月,飞利浦与芬兰奥卢大学医院签署了长期策略合作伙伴关係,提供先进的影像导引专科护理。它们都将配备飞利浦影像导引治疗系统 Azurion 和先进的影像引导治疗平台 FlexArm,提供最新的创新技术,帮助医生提高效率、工作流程和治疗结果。
Title: Global Phototherapy Equipment Market Size, Share & Trends Analysis Report by Product (Conventional Phototherapy Equipment, LED Phototherapy Equipment, and Fiber Optic Phototherapy Equipment), by Application (Skin Disease Treatment and Neonatal Jaundice Management), and by End-user (Hospitals, Clinics and Homecare),Forecast Period (2023-2030).
Global phototherapy equipment market is anticipated to grow at a CAGR of 5.2% during the Forecast Period (2023-2030). owing to increase in the prevalence of skin diseases, rise in incidence of neonatal jaundice, continuous technological advancements in the area of phototherapy, and adoption of LED-based phototherapy equipment. Phototherapy equipment is used for the treatment of various skin-related diseases such as mycosis fungoides, psoriasis, morphea, vitiligo, and others.
The global phototherapy equipment market is segmented by product, application, and end-user. Based on the product, the market is sub-segmented into conventional phototherapy equipment, led phototherapy equipment, and fiber optic phototherapy equipment. Based on the application, the market is sub-segmented into skin disease treatment and neonatal jaundice management. Further, based on end-users, the market is sub-segmented into hospitals, clinics, and home care. Among the products, the LED phototherapy equipment sub-segment is anticipated to hold a considerable share of the market. LED-based phototherapy is used to treat skin diseases such as fine lines, psoriasis, and acne. The rise in the number of people suffering from such skin conditions is expected to boost the demand for LED-based phototherapy devices. Acne is the most common skin condition that people experience. An estimated 80% of people ages 11 to 30 will have at least a mild form of acne making it the eighth most prevalent disease worldwide.
Among the applications, the skin disease treatment sub-segment is expected to hold a considerable share of the global phototherapy equipment market. Phototherapy is a highly effective therapy for a variety of skin diseases. Phototherapy uses specific wavelengths of light to reduce inflammation, slow skin cell proliferation, and improve healing. Phototherapy is a non-invasive treatment option that does not require surgical procedures or the administration of drugs. This makes it a good choice for people who prefer non-pharmacological treatments or who cannot take certain medications. Phototherapy also reduces the redness, swelling, and itching associated with psoriasis by suppressing the hyperactive immune response.
Increasing skin diseases in countries such as the US, China, and India have accounted for the rise in the use of phototherapy equipment. According to the National Psoriasis Foundation, Psoriatic disease impacts more than 8 million people in the US and 125 million people globally. Genetics are crucial because if one parent has psoriasis, a child has about a 28% chance of developing psoriasis. If both parents have psoriasis, a child has approximately a 65% chance of developing psoriasis. The immune system mistakenly assaults healthy cells in autoimmune skin illnesses such as vitiligo and alopecia areata, resulting in depigmentation or hair loss. Phototherapy can help modify the immune response, lowering the body's attack on tissues.
The global phototherapy equipment market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America. Among these, North America is anticipated to hold a prominent share of the market across the globe, owing to the rising occurrence of neonatal jaundice and skin diseases and increasing awareness among the people towards the use of new technologies.
Among all regions, the Asia-Pacific region is anticipated to grow at a considerable CAGR over the forecast period due to the rising construction of hospitals and specialized clinics to offer effective healthcare solutions. Apart from this, the increasing healthcare expenditure among the masses is contributing to the growth of the market. In 2019, China's healthcare import and export volumes both saw an increase, reaching the highest levels since 2011. Europe, Asia, and North America were China's top three continental partners for healthcare foreign trade. Major factors and drivers that are shaping the sector in China, especially the increasingly supporting role of the Chinese government in issuing key development plans and regulations, as well as the rapidly aging Chinese population. China's pharmaceutical industry has been steadily expanding and is predicted to reach $161.8 billion by the end of 2023, accounting for around 30% of the worldwide market. However, because top Chinese pharmaceutical businesses and multinational MNC pharmaceutical companies (including those from the US) have dominated most market sales, chances for US SME pharmaceutical companies to explore are restricted.
The major companies serving the phototherapy equipment market include: Daavlin Company, Aeroflow, Inc., Philips Lighting Holding B.V., Signify Holding, Atom Medical Corporation, Herbert Waldmann GmbH & Co. KG, Hill-Rom Holdings, Inc., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in April 2022, Philips signed a long-term strategic partnership with Oulu University Hospital Finland to deliver advanced image-guided specialist care. They will all be equipped with Philips' image-guided therapy system Azurion with FlexArm an advanced image-guided therapy platform that offers the latest innovations to help physicians improve efficiency, workflow, and treatment outcomes.